3.35
price up icon1.82%   0.06
after-market アフターアワーズ: 3.20 -0.15 -4.48%
loading
前日終値:
$3.29
開ける:
$3.46
24時間の取引高:
53,721
Relative Volume:
1.67
時価総額:
$140.80M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-31.63%
1か月 パフォーマンス:
-39.42%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$2.99
$3.46
1週間の範囲:
Value
$2.92
$4.84
52週間の値動き範囲:
Value
$2.92
$6.2324

Tuhura Biosciences Inc Stock (HURA) Company Profile

Name
名前
Tuhura Biosciences Inc
Name
セクター
Healthcare (1195)
Name
電話
813-875-6600
Name
住所
10500 UNIVERSITY CENTER DR., TAMPA
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
HURA's Discussions on Twitter

HURA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
HURA 3.35 140.80M 0 0 0 0.00
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Tuhura Biosciences Inc (HURA) 最新ニュース

pulisher
Nov 15, 2024

TuHURA Biosciences Announces Executive Salary and Stock Options - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

TuHURA Biosciences Inc (HURA) Quarterly 10-Q Report - Quartz

Nov 14, 2024
pulisher
Nov 08, 2024

TuHURA Biosciences Inc expected to post a loss of 10 cents a shareEarnings Preview - XM

Nov 08, 2024
pulisher
Oct 23, 2024

TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - AccessWire

Oct 23, 2024
pulisher
Oct 22, 2024

TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event - AccessWire

Oct 22, 2024
pulisher
Oct 19, 2024

TuHURA Biosciences finalizes merger, sets Phase 3 trial - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - PR Newswire

Oct 18, 2024
pulisher
Oct 18, 2024

HURA Stock Price and Chart — NASDAQ:HURA - TradingView

Oct 18, 2024
pulisher
Oct 17, 2024

TuHURA Biosciences finalizes merger, sets Phase 3 trial By Investing.com - Investing.com South Africa

Oct 17, 2024
pulisher
Oct 17, 2024

TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Lowenstein Represents Kintara Therapeutics in Merger with TuHURA Biosciences - Lowenstein Sandler LLP

Oct 17, 2024
pulisher
Oct 16, 2024

Kintara Therapeutics Announces Stock Split Amid Merger - TipRanks

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara approves reverse stock split, rebrands as TuHURA Biosciences - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara announces 1-for-35 reverse stock split in connection with TuHURA merger - TipRanks

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara approves 1-for-35 reverse stock split before merger - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara approves 1-for-35 reverse stock split before merger By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara approves reverse stock split, rebrands as TuHURA Biosciences By Investing.com - Investing.com Australia

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - Quantisnow

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara amends CVR issuance terms ahead of TuHURA merger By Investing.com - Investing.com Canada

Oct 16, 2024
pulisher
Oct 16, 2024

Kintara amends CVR issuance terms ahead of TuHURA merger - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - StockTitan

Oct 15, 2024
pulisher
Oct 14, 2024

Kintara stock climbs 10% on TuHURA merger update (NASDAQ:KTRA) - Seeking Alpha

Oct 14, 2024
pulisher
Oct 14, 2024

Kintara Therapeutics Set for Strategic Merger and CVR Issuance - TipRanks

Oct 14, 2024
pulisher
Oct 09, 2024

Stockholders Fail to Approve Proposal to Reincorporate Nevada Corporation in Delaware - The National Law Review

Oct 09, 2024
pulisher
Oct 08, 2024

Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update - StockTitan

Oct 08, 2024
pulisher
Oct 04, 2024

Kintara shareholders approve key proposals; Charter change fails By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Kintara shareholders approve key proposals; Charter change fails - Investing.com

Oct 04, 2024
pulisher
Oct 02, 2024

Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1 - StockTitan

Oct 02, 2024
pulisher
Sep 26, 2024

Kintara Therapeutics modifies merger terms with TuHURA Biosciences - Investing.com

Sep 26, 2024
pulisher
Sep 24, 2024

Kintara Urges Shareholder Votes for TuHURA Biosciences Merger - TipRanks

Sep 24, 2024
pulisher
Sep 20, 2024

Kintara Therapeutics Seeks Approval for Key Merger with TuHURA Biosciences - TipRanks

Sep 20, 2024
pulisher
Sep 19, 2024

Kintara Announces Special Meeting for Proposed TuHURA Merger - TipRanks

Sep 19, 2024
pulisher
Sep 18, 2024

Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences | KTRA Stock News - StockTitan

Sep 18, 2024
pulisher
Sep 11, 2024

Kintara Therapeutics Advances with TuHURA Merger and Trials - TipRanks

Sep 11, 2024
pulisher
Sep 09, 2024

Kintara Therapeutics Calls for Vote on TuHURA Merger - TipRanks

Sep 09, 2024
pulisher
Sep 04, 2024

Kintara Therapeutics announces special meeting details By Investing.com - Investing.com Australia

Sep 04, 2024
pulisher
Aug 19, 2024

TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer - PR Newswire

Aug 19, 2024
pulisher
Jul 13, 2024

Kintara Therapeutics restructures share designations - Investing.com

Jul 13, 2024
pulisher
Jul 08, 2024

Kintara Therapeutics Eyes Acquisition Amidst Cautionary Advice - TipRanks

Jul 08, 2024
pulisher
Jul 01, 2024

Kintara and TuHURA announce merger and clinical progress - Investing.com

Jul 01, 2024
pulisher
Jun 03, 2024

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carci - PR Newswire

Jun 03, 2024
pulisher
May 27, 2024

Laurel Lee from Florida's 15th district invests in TuHURA Biosciences By Investing.com - Investing.com

May 27, 2024
pulisher
May 14, 2024

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results - PR Newswire

May 14, 2024
pulisher
Apr 23, 2024

Wolfe Research cuts Warner Bros Discovery stock to underperform By Investing.com - Investing.com Nigeria

Apr 23, 2024
pulisher
Apr 09, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc.KTRA - PR Newswire

Apr 09, 2024
pulisher
Apr 04, 2024

Kintara and TuHURA in merger deal to advance oncology pipeline - Pharmaceutical Technology

Apr 04, 2024
pulisher
Apr 03, 2024

Why Is Kintara Therapeutics (KTRA) Stock Up 103% Today? - InvestorPlace

Apr 03, 2024
pulisher
Mar 27, 2024

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab - PR Newswire

Mar 27, 2024
pulisher
Mar 04, 2024

Kintara Therapeutics And TuHURA Biosciences To Merge - Contract Pharma

Mar 04, 2024
pulisher
Feb 12, 2024

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer - PR Newswire

Feb 12, 2024

Tuhura Biosciences Inc (HURA) 財務データ

Tuhura Biosciences Inc (HURA) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):